Proctitis following stereotactic body radiation therapy for prostate cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1748-717X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Proctitis following stereotactic body radiation therapy for prostate cancer ; volume:9 ; number:1 ; day:12 ; month:12 ; year:2014 ; pages:1-10 ; date:12.2014
Radiation oncology ; 9, Heft 1 (12.12.2014), 1-10, 12.2014

Creator: Joh, Daniel Y.

Contributor: Chen, Leonard N.
Porter, Gerald
Bhagat, Aditi
Sood, Sumit
Kim, Joy S.
Moures, Rudy
Yung, Thomas
Lei, Siyuan
Collins, Brian T.
Ju, Andrew W.
Suy, Simeng
Carroll, John
Lynch, John H.
Dritschilo, Anatoly
Collins, Sean P.
SpringerLink (Online service)

DOI: 10.1186/s13014-014-0277-4

URN: urn:nbn:de:1111-2016072619173

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Joh, Daniel Y.
Chen, Leonard N.
Porter, Gerald
Bhagat, Aditi
Sood, Sumit
Kim, Joy S.
Moures, Rudy
Yung, Thomas
Lei, Siyuan
Collins, Brian T.
Ju, Andrew W.
Suy, Simeng
Carroll, John
Lynch, John H.
Dritschilo, Anatoly
Collins, Sean P.
SpringerLink (Online service)

Other Objects (12)

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Aufsatzsammlung

Stereotactic body radiation therapy

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

$Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer$

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer

Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

Stereotactic body radiation therapy use for high risk prostate cancer in the United States

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Aufsatzsammlung

Stereotactic body radiation therapy

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

$Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer$

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer

Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

Stereotactic body radiation therapy use for high risk prostate cancer in the United States

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Aufsatzsammlung

Stereotactic body radiation therapy

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

$Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer$

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer

Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

Stereotactic body radiation therapy use for high risk prostate cancer in the United States

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Proctitis following stereotactic body radiation therapy for prostate cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Stereotactic body radiation therapy

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer

Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

Stereotactic body radiation therapy use for high risk prostate cancer in the United States

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Stereotactic body radiation therapy

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer

Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

Stereotactic body radiation therapy use for high risk prostate cancer in the United States

Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Stereotactic body radiation therapy

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Radiation oncologists’ attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer

Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI

Stereotactic body radiation therapy use for high risk prostate cancer in the United States

Related objects

Reset password